ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,114Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 71

$1.32M Total Retail Price of All Prescriptions

Rank: 6 out of 71

1,303 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
1% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 1,303 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

2% of this provider’s 1,303 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

2% of this provider’s 10,188 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 34%.

Prescription Price

$100 was the average price of a prescription from this provider, compared to $113 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
DONEPEZIL HCL 1,544 1,442 1 1
NAMENDA 1,515 1,469 2 2
GABAPENTIN 705 354 3 3
CARBIDOPA-LEVODOPA 553 479 4 4
EXELON 433 427 5 6
GALANTAMINE HBR 352 348 6 5
PRAMIPEXOLE DIHYDROCHLORIDE 317 286 7 8
SERTRALINE HCL 282 242 8 7
DICLOFENAC POTASSIUM 266 136 9 25
CLOPIDOGREL 189 153 10 19
PAROXETINE HCL 182 125 11 27
LEVETIRACETAM 176 114 12 9
LYRICA 172 99 13 12
CITALOPRAM HBR 168 141 14 10
PLAVIX 165 130 15 20
DILANTIN 148 94 16 28
SIMVASTATIN 146 105 17 13
PRIMIDONE 144 127 18 23
ROPINIROLE HCL 143 130 19 35
OMEPRAZOLE 138 85 20 36
NABUMETONE 137 74 21 31
ZOLPIDEM TARTRATE 130 104 22 15
AMITRIPTYLINE HCL 129 74 R 23 18
AMANTADINE 125 113 24 41
RANITIDINE HCL 121 86 25 24
TRAMADOL HCL-ACETAMINOPHEN 119 79 26 11
TIZANIDINE HCL 116 32 27 17
QUETIAPINE FUMARATE 102 100 28 14
FLUOXETINE HCL 98 76 29 44
ASPIRIN EC 94 94 30 46
OXCARBAZEPINE 92 55 31 38
RIVASTIGMINE 90 90 32 42
MELOXICAM 90 24 32 56
BACLOFEN 89 44 34 45
NORTRIPTYLINE HCL 86 76 35 43
SYNTHROID 86 81 35 55
SELEGILINE HCL 85 77 37 60
ETODOLAC 81 22 38 33
LAMOTRIGINE 80 43 39 21
BENZTROPINE MESYLATE 78 44 R 40 68
AMLODIPINE BESYLATE 76 63 41 59
TEGRETOL XR 74 28 42 114
LEVOTHYROXINE SODIUM 72 59 43 61
KEPPRA 69 44 44 77
RISPERIDONE 68 63 45 22
ENALAPRIL MALEATE 67 46 46 48
CARBIDOPA-LEVODOPA-ENTACAPONE 64 56 47 91
INDOMETHACIN 60 25 R 48 94
ATENOLOL 58 45 49 115
NAPROXEN 58 36 49 74
SEROQUEL 58 58 49 34
MECLIZINE HCL 53 25 52 54
DIPYRIDAMOLE 51 51 R 53 81
VENLAFAXINE HCL ER 50 46 54 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.